Adocia, Innovative medicine for everyone, everywherehttp://www.adocia.comhttp://www.adocia.com/img/logoPop.pnghttp://www.adocia.frFri, 26 Apr 2013 00:00:00 +0200Release of 2012 Reference Document (French only)http://www.adocia.fr/repressrelease/5_130422_Adocia_Mise_a_disposition_du_doc_de_ref_2012_FR_VF_NVI.pdfWed, 24 Apr 2013 00:00:00 +0200Q1 2013 revenueshttp://www.adocia.fr/repressrelease/15_130424_Adocia_CA_Q1_ENG_VF_NVI.pdfTue, 23 Apr 2013 00:00:00 +0200Liquidity agreement (French only)http://www.adocia.fr/repressrelease/8_130423_Adocia_Contrat_de_Liquidite_FRVF_NVI.pdfWed, 20 Mar 2013 00:00:00 +01002012 Annual Results http://www.adocia.fr/repressrelease/8_130320_Press_Release_Adocia_2012_Annual_Results_ENG_VF_NVI.pdfMon, 18 Mar 2013 00:00:00 +0100Adocia announces its phase III development program for the treatment of diabetic foot ulcer. This program has been validated by scientific advice from the European Medicines Agencyhttp://www.adocia.fr/repressrelease/11_130318_Press_Release-BC_PDGF-BB_Scientific_Advice_VF_GSO.pdfTue, 19 Feb 2013 00:00:00 +0100ADOCIA reports a revenue multiplied by 2.5 with a strong cash position for 2012http://www.adocia.fr/repressrelease/7_130219_Communique_de_Presse_Adocia_Chiffre_d_affaires_2012_ENG_VF_NVI.pdfWed, 06 Feb 2013 00:00:00 +0100Bio CEO & Investor Conference - 11-12 February 2013 - The Waldorf Astoria, New York, USAhttp://www.adocia.fr/repressrelease/Mon, 07 Jan 2013 00:00:00 +0100Adocia announces its financial calendar for 2013 as well as its participation to upcoming investor conferenceshttp://www.adocia.fr/repressrelease/9_130102 Press Release Adocia Financial Calendar 2013 VF NVI.pdfTue, 30 Oct 2012 00:00:00 +0100Adocia announces the strong growth of its turnoverhttp://www.adocia.fr/repressrelease/11_121030 Adocia CA Q3 ENG VF NVI.pdfMon, 22 Oct 2012 00:00:00 +0200Adocia is extending its intellectual property to new formulations of monoclonal antibodieshttp://www.adocia.fr/repressrelease/7_121022 ADOCIA_Brevets mAbs EN.pdfMon, 01 Oct 2012 00:00:00 +0200EASD 2012 - 48th Annual Meeting of the European Association for the Study of Diabetes - 1-5 October 2012, Messe Süd, Berlin, Germanyhttp://www.adocia.fr/repressrelease/Mon, 24 Sep 2012 00:00:00 +0200Large & Midcap Event - 24-25 September 2012, Parishttp://www.adocia.fr/repressrelease/Wed, 12 Sep 2012 00:00:00 +0200Bio India International Conference - 12-13 September 2012, Grand Hyatt, Mumbai, Indiahttp://www.adocia.fr/repressrelease/Fri, 07 Sep 2012 00:00:00 +0200DFSICON 2012 - 11th Annual Meeting of Diabetic Foot Society of India - 7-9 September 2012, Hyderabad, Indiahttp://www.adocia.fr/repressrelease/Tue, 04 Sep 2012 00:00:00 +0200SFAF meeting - Half year 2012 results. At 14:30, NYSE EURONEXT, room Auditorium - 3 rue Cambon - 75001 Parishttp://www.adocia.fr/repressrelease/Mon, 03 Sep 2012 00:00:00 +0200Financial results and business report for the first half of 2012http://www.adocia.fr/repressrelease/14_120903_Adocia_Press_Release_Half_Year_June_2012_EN_VF_NVI.pdfMon, 03 Sep 2012 00:00:00 +0200http://www.adocia.fr/repressrelease/Sun, 02 Sep 2012 00:00:00 +0200WUWHS 2012 - 4th Congress of the World Union of Wound Healing Societies - 2-6 September 2012, Yokohama, Japonhttp://www.adocia.fr/repressrelease/Wed, 13 Jun 2012 00:00:00 +0200Adocia announces a strengthened intellectual property on its lead project for its chronic wounds treatmenthttp://www.adocia.fr/repressrelease/7_120613_Press_Release_ADOCIA_Patents_PDGF_EN_VF_NVI.pdfWed, 30 May 2012 00:00:00 +0200Additional contribution to Liquidity Agreement with Dexia Securities France (French only)http://www.adocia.fr/repressrelease/11_120529_CP_contrat_de_liquidite_n2_VF_NVI.pdfThu, 26 Apr 2012 00:00:00 +0200ADOCIA maintains its dynamic growth: revenue of 1st quarter 2012http://www.adocia.fr/repressrelease/Mon, 23 Apr 2012 00:00:00 +0200ADOCIA reports positive phase II clinical resultshttp://www.adocia.fr/repressrelease/8_120423_CP_PDGFBB_EN.pdfMon, 02 Apr 2012 00:00:00 +02002011 annual financial results - 2011: a key milestone in ADOCIA's developmenthttp://www.adocia.fr/repressrelease/8_120402CPFYR2011ENGVF.pdfThu, 15 Mar 2012 00:00:00 +0100ADOCIA increases the size of its Initial Public Offering to E27.4 million through the partial...http://www.adocia.fr/repressrelease/120315_CP_surallocation_ENG_VF_SFL.pdfThu, 15 Mar 2012 00:00:00 +0100Liquidity agreement with Dexia Securities France (French only)http://www.adocia.fr/repressrelease/7_120315CPcontratdeliquiditeVFSFL.pdfWed, 29 Feb 2012 00:00:00 +0100ADOCIA reports strong growth in operating income in 2011http://www.adocia.fr/repressrelease/120229-Adocia-communiqueCA2011VENG.pdfTue, 28 Feb 2012 00:00:00 +0100ADOCIA reports positive phase IIa clinical results on its fast-acting human insulin, HinsBet®http://www.adocia.fr/repressrelease/120227_ADOCIA_IIa_Hinsbet_ENG_VF_NVI.pdfTue, 14 Feb 2012 00:00:00 +0100ADOCIA carries out, with much success, the first IPO of the year...http://www.adocia.fr/repressrelease/5_CommuniqueADOCIASuccesVFENG.pdfThu, 26 Jan 2012 00:00:00 +0100ADOCIA launches its IPO on the NYSE Euronext regulated market in Parishttp://www.adocia.fr/repressrelease/CommuniqueADOCIANotedOperationUK.pdfWed, 18 Jan 2012 00:00:00 +0100ADOCIA announces the registration of its Document de base (French only)http://www.adocia.fr/repressrelease/8_120118_CP_ADOCIAEnregistrementDDB_VF.pdfFri, 24 Jun 2011 00:00:00 +0200ADOCIA launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet®http://www.adocia.fr/repressrelease/12_110624PR_Adocia_Insulin_Action_rapide_ENG_VF.pdfWed, 15 Jun 2011 00:00:00 +0200ADOCIA announces the communication of its clinical results at three major conferenceshttp://www.adocia.fr/repressrelease/6_110615_PRAdocia_3_major_conferences_ENG_VF.pdfTue, 15 Mar 2011 00:00:00 +0100ADOCIA reports positive phase I clinical results on HinsBet®, a fast-acting human insulinhttp://www.adocia.fr/repressrelease/10_110315PRInsulinVF-NVI-ENG.pdfTue, 05 Jan 2010 00:00:00 +0100Adocia announces today the closing of its second financing round of 14 M€.http://www.adocia.fr/repressrelease/7_100104_Press_Release_Adocia_VF_NVI.pdfMon, 21 Jan 2008 00:00:00 +0100ADOCIA has raised 12 M€ in order to finance its development of innovative pharmaceutical products...http://www.adocia.fr/repressrelease/7_ADOCIA Press Release UK.pdf